Human Molecular Genetics, 2002, Vol. 11, No. 23 2969-2977
© 2002 Oxford University Press
Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides
1Medical Research Council, Mammalian Genetics Unit, Harwell, Didcot OX11 0RD, UK, 2Department of Biological Anthropology, University of Oxford, Oxford, UK, 3INSERM U 525, Faculté de Médecine Pitié-Salpêtrière, Université Paris VI, Paris, France, 4Centre National de Génotypage, Evry, France, 5Department of Preventive Medicine and Epidemiology, Loyola University Medical Center, Maywood, Illinois, USA, 6Department of Pediatrics/Institute for Child Health, College of Medicine, University of Ibadan, Ibadan, Nigeria and 7Department of Cardiovascular Medicine, University of Oxford, The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford OX3 7BN, UK
Received July 26, 2002; Accepted September 9, 2002
Circulating angiotensin-1-converting enzyme (ACE) is a highly heritable trait, and a major component of the genetic variance maps to the region of the ACE gene. The strong effect of the locus, and the interest in ACE as a candidate gene for cardiovascular disorders, has led to extensive investigation of its relationship to the ACE phenotype, providing one of the most complete examples of quantitative trait locus (QTL) analysis in humans. Resequencing of ACE followed by haplotype analysis in families of British and French origin has shown that the genetic variants that are primarily associated with the ACE trait map to an 18 kb interval flanked by two intragenic, ancestral recombination breakpoints. This critical interval contains dozens of ACE-associated variants in Caucasians, but identification of which of these directly influence ACE concentration is ambiguous because of the almost complete linkage disequilibrium in European populations. In a complementary sequencing and genotyping study of individuals from West African families, we show that this population has much greater haplotype diversity across the gene. Through analysis of the contrasting relationships of the trait phenotype with haplotypes that carry different allelic combinations from those observed in Caucasians, we demonstrate that (at least) two major intragenic sites within the critical interval and (at least) one minor promoter site are associated with the ACE quantitative trait through additive effects. These results point to the importance of analysing diverse populations with different gene genealogies in gene-association studies.
* To whom correspondence should be addressed: Tel: +44 1865287601; Fax: +44 1865287501; Email: martin.farrall{at}well.ox.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M.-G. Hong, C. Reynolds, M. Gatz, B. Johansson, J. C. Palmer, H. F. Gu, K. Blennow, P. G. Kehoe, U. de Faire, N. L. Pedersen, et al. Evidence that the gene encoding insulin degrading enzyme influences human lifespan Hum. Mol. Genet., August 1, 2008; 17(15): 2370 - 2378. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Kara, E Ozkok, M Aydin, N Orhan, Y Cetinkaya, M Gencer, G Kilic, and H Tireli Combined Effects of ACE and MMP-3 Polymorphisms On Migraine Development Cephalalgia, March 1, 2007; 27(3): 235 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Biller, G. Zissel, B. Ruprecht, M. Nauck, A. Busse Grawitz, and J. Muller-Quernheim Genotype-corrected reference values for serum angiotensin-converting enzyme Eur. Respir. J., December 1, 2006; 28(6): 1085 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Frere, D.-A. Tregouet, P.-E. Morange, N. Saut, D. Kouassi, I. Juhan-Vague, L. Tiret, and M.-C. Alessi Fine mapping of quantitative trait nucleotides underlying thrombin-activatable fibrinolysis inhibitor antigen levels by a transethnic study Blood, September 1, 2006; 108(5): 1562 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.A. Sayed-Tabatabaei, B.A. Oostra, A. Isaacs, C.M. van Duijn, and J.C.M. Witteman ACE Polymorphisms Circ. Res., May 12, 2006; 98(9): 1123 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Catarsi, R. Ravazzolo, F. Emma, D. Fruci, L. Finos, A. Frau, G. Morreale, A. Carrea, and G. M. Ghiggeri Angiotensin-converting enzyme (ACE) haplotypes and cyclosporine A (CsA) response: a model of the complex relationship between ACE quantitative trait locus and pathological phenotypes Hum. Mol. Genet., August 15, 2005; 14(16): 2357 - 2367. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Lehmann, M. Cortina-Borja, D. R. Warden, A. D. Smith, K. Sleegers, J. A. Prince, C. M. van Duijn, and P. G. Kehoe Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease Am. J. Epidemiol., August 15, 2005; 162(4): 305 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lei, I. N. M. Day, and I. Vorechovsky Exonization of AluYa5 in the human ACE gene requires mutations in both 3' and 5' splice sites and is facilitated by a conserved splicing enhancer Nucleic Acids Res., July 14, 2005; 33(12): 3897 - 3906. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zhang, F. Sun, and H. Zhao HAPLORE: a program for haplotype reconstruction in general pedigrees without recombination Bioinformatics, January 1, 2005; 21(1): 90 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Katzov, A. M. Bennet, P. Kehoe, B. Wiman, M. Gatz, K. Blennow, B. Lenhard, N. L. Pedersen, U. de Faire, and J. A. Prince A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity Hum. Mol. Genet., November 1, 2004; 13(21): 2647 - 2657. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Gu, S. Efendic, S. Nordman, C.-G. Ostenson, K. Brismar, A. J. Brookes, and J. A. Prince Quantitative Trait Loci Near the Insulin-Degrading Enzyme (IDE) Gene Contribute to Variation in Plasma Insulin Levels Diabetes, August 1, 2004; 53(8): 2137 - 2142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Farrall Quantitative genetic variation: a post-modern view Hum. Mol. Genet., April 1, 2004; 13(90001): R1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Kammerer, N. Gouin, P. B. Samollow, J. F. VandeBerg, J. E. Hixson, S. A. Cole, J. W. MacCluer, and L. D. Atwood Two Quantitative Trait Loci Affect ACE Activities in Mexican-Americans Hypertension, February 1, 2004; 43(2): 466 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Haiman, S. O. Henderson, P. Bretsky, L. N. Kolonel, and B. E. Henderson Genetic Variation in Angiotensin I-Converting Enzyme (ACE) and Breast Cancer Risk: The Multiethnic Cohort Cancer Res., October 15, 2003; 63(20): 6984 - 6987. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G Kehoe Review: The renin-angiotensin-aldosterone system and Alzheimer's disease? Journal of Renin-Angiotensin-Aldosterone System, June 1, 2003; 4(2): 80 - 93. [Abstract] [PDF] |
||||
![]() |
X. Zhu, Y.-P. C. Chang, D. Yan, A. Weder, R. Cooper, A. Luke, D. Kan, and A. Chakravarti Associations Between Hypertension and Genes in the Renin-Angiotensin System Hypertension, May 1, 2003; 41(5): 1027 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Kehoe, H. Katzov, L. Feuk, A. M. Bennet, B. Johansson, B. Wiman, U. d. Faire, N. J. Cairns, G. K. Wilcock, A. J. Brookes, et al. Haplotypes extending across ACE are associated with Alzheimer's disease Hum. Mol. Genet., April 15, 2003; 12(8): 859 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Cooper and B. M. Psaty Genomics and Medicine: Distraction, Incremental Progress, or the Dawn of a New Age? Ann Intern Med, April 1, 2003; 138(7): 576 - 580. [Abstract] [Full Text] [PDF] |
||||












